Work

Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles

Year: 2019

Type: article

Abstract: The inability to completely excise peritoneal metastatic tumors by debulking surgery as well as resistance to chemotherapy are the major clinical challenges for ovarian cancer treatment. This targeted cancer therapy has the potential for the development of effective treatment for metastatic ovarian cancer.

Source: Theranostics

DOI: 10.7150/thno.29964

Authors: Minati Satpathy, Liya Wang, Rafal J. Zielinski, Weiping Qian, Y. Andrew Wang, Aaron M. Mohs, Brad A. Kairdolf, Xin Ji, Jacek Capala, Malgorzata Lipowska, Shuming Nie, Hui Mao, Lily Yang

Institutions: Emory University, The University of Texas MD Anderson Cancer Center, Ocean NanoTech (United States), National Institutes of Health, National Cancer Institute

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,671

Funders: Purdue University, University of Rochester, National Institutes of Health, National Cancer Institute

Awards: G1483782529, G2067888419, G318930586, G3687267199, G405246358, Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy, G567615931, G5988735914

OpenAlex ID: W2911411908

FWCI: 4.174

Cites: 50

Cited by: 117

Related to: 10